Page last updated: 2024-09-02

1-hydroxymethylmidazolam and Hepatic Failure

1-hydroxymethylmidazolam has been researched along with Hepatic Failure in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bastien, O; Bolon, M; Boulieu, R; Flamens, C; Lehot, JJ1
de Hoog, M; de Wildt, SN; van den Anker, JN; van der Giesen, E; Vinks, AA1

Trials

1 trial(s) available for 1-hydroxymethylmidazolam and Hepatic Failure

ArticleYear
[Use of midazolam in postoperative sedation of patients with multiple organ failure treated with hemodiafiltration. Clinical study and pharmacokinetics].
    Annales francaises d'anesthesie et de reanimation, 2002, Volume: 21, Issue:9

    Topics: Adjuvants, Anesthesia; Aged; Biotransformation; Chromatography, Liquid; Female; Half-Life; Hemofiltration; Humans; Liver Failure; Male; Midazolam; Middle Aged; Multiple Organ Failure; Renal Insufficiency

2002

Other Studies

1 other study(ies) available for 1-hydroxymethylmidazolam and Hepatic Failure

ArticleYear
Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
    Critical care medicine, 2003, Volume: 31, Issue:7

    Topics: Adolescent; Aryl Hydrocarbon Hydroxylases; Bayes Theorem; Child; Child, Preschool; Conscious Sedation; Critical Care; Cytochrome P-450 CYP3A; Female; Humans; Hypnotics and Sedatives; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Liver Failure; Male; Mathematical Computing; Metabolic Clearance Rate; Midazolam; Oxidoreductases, N-Demethylating; Renal Insufficiency

2003